Ozempic 'Significantly' Lowered 'Alcohol Craving' in First Clinical Trial, with Those Taking the Drug Drinking 40% Less
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink